Literature DB >> 11263518

Outbreak of multidrug-resistant tuberculosis at a methadone treatment program.

C Conover1, R Ridzon, S Valway, L Schoenstadt, J McAuley, I Onorato, W Paul.   

Abstract

SETTING: An out-patient methadone treatment program MTP).
OBJECTIVE: To investigate transmission of multidrug-resistant tuberculosis (MDR-TB) in the MTP.
DESIGN: Cases were defined as MTP clients or staff who developed TB between 1 January 1994 and 1 January 1996, with at least one positive culture for Mycobacterium tuberculosis resistant to isoniazid and rifampin. Contacts were identified, located and evaluated.
RESULTS: Thirteen cases of MDR-TB occurred among 462 clients and staff. One fifth (6/30) of the members of a counseling group for human immunodeficiency virus (HIV) infected clients developed MDR-TB. Individuals known to be HIV positive were at greater risk for TB than those who were HIV negative (RR 5.2, 95%CI 1.2-22.7). Of 449 clients and staff identified as contacts, 393 (87.5%) were located and screened. Among those with a negative baseline tuberculin skin test, 18.5% (56/303) were skin test converters. Attendance at the MTP during a period when the index case was infectious was associated with an increased risk of conversion (RR 2.5, 95%CI 1.1-6.0).
CONCLUSION: Extensive transmission of MDR-TB occurred at an out-patient MTP serving numerous clients with HIV infection. This outbreak underscores the importance of developing effective strategies to prevent TB transmission in this setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263518

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Active case finding for tuberculosis among people who inject drugs on methadone treatment in Dar es Salaam, Tanzania.

Authors:  A Gupta; J Mbwambo; I Mteza; S Shenoi; B Lambdin; C Nyandindi; B I Doula; S Mfaume; R D Bruce
Journal:  Int J Tuberc Lung Dis       Date:  2014-07       Impact factor: 2.373

2.  Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care.

Authors:  Haider Abdulrazzaq Abed Al-Darraji; Kee Cheong Wong; David Gan Eng Yeow; Jeannia Jiani Fu; Kelsey Loeliger; Christopher Paiji; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2013-09-24

3.  Tuberculosis among drug users and homeless persons: impact of voluntary X-ray investigation on active case finding.

Authors:  U Goetsch; O K Bellinger; K-L Buettel; R Gottschalk
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

4.  Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.

Authors:  Elinore F McCance-Katz; David E Moody; Sudha Prathikanti; Gerald Friedland; Petrie M Rainey
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

Review 5.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 6.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

7.  Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.

Authors:  Tetyana I Vasylyeva; Pavlo Smyrnov; Steffanie Strathdee; Samuel R Friedman
Journal:  J Int AIDS Soc       Date:  2020-07       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.